drugset / Trial / NCT07275242
A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the pharmacokinetics , safety, tolerability and efficacy in patients with solid tumor.
Timeline
- Start
- 2025-12-23
- Primary completion
- 2027-06
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trastuzumab Rezetecan | Monoclonal antibody | — | Subcutaneous |